Biocept Announces Study To Isolate Circulating Tumor Cells From Blood
Dec 6th 2007Drug InformationBlood
Biocept, an emerging leader in biotechnology, is initiating a collaborative study with the University of Texas M.D. Anderson Cancer Center to investigate the ability to isolate circulating tumor cells (CTCs) in blood. The study will use Biocept’s proprietary CEE(TM) (Cell Enrichment and Extraction) technology, designed to capture rare cells from a larger heterogeneous cell population. The focus of this study is ovarian cancer. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
